nodes	percent_of_prediction	percent_of_DWPC	metapath
Fondaparinux sodium—Vertigo—Triamcinolone—ankylosing spondylitis	0.00185	0.00185	CcSEcCtD
Fondaparinux sodium—Syncope—Triamcinolone—ankylosing spondylitis	0.00185	0.00185	CcSEcCtD
Fondaparinux sodium—Vertigo—Methylprednisolone—ankylosing spondylitis	0.00185	0.00185	CcSEcCtD
Fondaparinux sodium—Syncope—Methylprednisolone—ankylosing spondylitis	0.00184	0.00184	CcSEcCtD
Fondaparinux sodium—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.00183	0.00183	CcSEcCtD
Fondaparinux sodium—Oedema—Prednisolone—ankylosing spondylitis	0.00183	0.00183	CcSEcCtD
Fondaparinux sodium—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.00181	0.00181	CcSEcCtD
Fondaparinux sodium—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.00181	0.00181	CcSEcCtD
Fondaparinux sodium—Shock—Prednisolone—ankylosing spondylitis	0.0018	0.0018	CcSEcCtD
Fondaparinux sodium—Cough—Triamcinolone—ankylosing spondylitis	0.0018	0.0018	CcSEcCtD
Fondaparinux sodium—Convulsion—Triamcinolone—ankylosing spondylitis	0.00179	0.00179	CcSEcCtD
Fondaparinux sodium—Tachycardia—Prednisolone—ankylosing spondylitis	0.00178	0.00178	CcSEcCtD
Fondaparinux sodium—Convulsion—Methylprednisolone—ankylosing spondylitis	0.00178	0.00178	CcSEcCtD
Fondaparinux sodium—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.00177	0.00177	CcSEcCtD
Fondaparinux sodium—Anxiety—Methylprednisolone—ankylosing spondylitis	0.00174	0.00174	CcSEcCtD
Fondaparinux sodium—Infestation NOS—Methotrexate—ankylosing spondylitis	0.00174	0.00174	CcSEcCtD
Fondaparinux sodium—Infestation—Methotrexate—ankylosing spondylitis	0.00174	0.00174	CcSEcCtD
Fondaparinux sodium—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.00174	0.00174	CcSEcCtD
Fondaparinux sodium—Flushing—Prednisone—ankylosing spondylitis	0.00174	0.00174	CcSEcCtD
Fondaparinux sodium—Renal failure—Methotrexate—ankylosing spondylitis	0.00171	0.00171	CcSEcCtD
Fondaparinux sodium—Angioedema—Dexamethasone—ankylosing spondylitis	0.00171	0.00171	CcSEcCtD
Fondaparinux sodium—Angioedema—Betamethasone—ankylosing spondylitis	0.00171	0.00171	CcSEcCtD
Fondaparinux sodium—Angiopathy—Prednisone—ankylosing spondylitis	0.0017	0.0017	CcSEcCtD
Fondaparinux sodium—Confusional state—Methylprednisolone—ankylosing spondylitis	0.00169	0.00169	CcSEcCtD
Fondaparinux sodium—Immune system disorder—Prednisone—ankylosing spondylitis	0.00169	0.00169	CcSEcCtD
Fondaparinux sodium—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.00168	0.00168	CcSEcCtD
Fondaparinux sodium—Oedema—Triamcinolone—ankylosing spondylitis	0.00168	0.00168	CcSEcCtD
Fondaparinux sodium—Vertigo—Dexamethasone—ankylosing spondylitis	0.00168	0.00168	CcSEcCtD
Fondaparinux sodium—Vertigo—Betamethasone—ankylosing spondylitis	0.00168	0.00168	CcSEcCtD
Fondaparinux sodium—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.00168	0.00168	CcSEcCtD
Fondaparinux sodium—Syncope—Dexamethasone—ankylosing spondylitis	0.00168	0.00168	CcSEcCtD
Fondaparinux sodium—Syncope—Betamethasone—ankylosing spondylitis	0.00168	0.00168	CcSEcCtD
Fondaparinux sodium—Arrhythmia—Prednisone—ankylosing spondylitis	0.00167	0.00167	CcSEcCtD
Fondaparinux sodium—Infection—Triamcinolone—ankylosing spondylitis	0.00167	0.00167	CcSEcCtD
Fondaparinux sodium—Infection—Methylprednisolone—ankylosing spondylitis	0.00167	0.00167	CcSEcCtD
Fondaparinux sodium—Haematuria—Methotrexate—ankylosing spondylitis	0.00166	0.00166	CcSEcCtD
Fondaparinux sodium—Shock—Triamcinolone—ankylosing spondylitis	0.00165	0.00165	CcSEcCtD
Fondaparinux sodium—Insomnia—Prednisolone—ankylosing spondylitis	0.00165	0.00165	CcSEcCtD
Fondaparinux sodium—Shock—Methylprednisolone—ankylosing spondylitis	0.00165	0.00165	CcSEcCtD
Fondaparinux sodium—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.00165	0.00165	CcSEcCtD
Fondaparinux sodium—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.00165	0.00165	CcSEcCtD
Fondaparinux sodium—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.00164	0.00164	CcSEcCtD
Fondaparinux sodium—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.00164	0.00164	CcSEcCtD
Fondaparinux sodium—Epistaxis—Methotrexate—ankylosing spondylitis	0.00164	0.00164	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Prednisolone—ankylosing spondylitis	0.00164	0.00164	CcSEcCtD
Fondaparinux sodium—Tachycardia—Triamcinolone—ankylosing spondylitis	0.00164	0.00164	CcSEcCtD
Fondaparinux sodium—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.00164	0.00164	CcSEcCtD
Fondaparinux sodium—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.00163	0.00163	CcSEcCtD
Fondaparinux sodium—Malnutrition—Prednisone—ankylosing spondylitis	0.00163	0.00163	CcSEcCtD
Fondaparinux sodium—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.00163	0.00163	CcSEcCtD
Fondaparinux sodium—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.00162	0.00162	CcSEcCtD
Fondaparinux sodium—Convulsion—Betamethasone—ankylosing spondylitis	0.00162	0.00162	CcSEcCtD
Fondaparinux sodium—Convulsion—Dexamethasone—ankylosing spondylitis	0.00162	0.00162	CcSEcCtD
Fondaparinux sodium—Anxiety—Dexamethasone—ankylosing spondylitis	0.00159	0.00159	CcSEcCtD
Fondaparinux sodium—Anxiety—Betamethasone—ankylosing spondylitis	0.00159	0.00159	CcSEcCtD
Fondaparinux sodium—Haemoglobin—Methotrexate—ankylosing spondylitis	0.00157	0.00157	CcSEcCtD
Fondaparinux sodium—Hypotension—Methylprednisolone—ankylosing spondylitis	0.00157	0.00157	CcSEcCtD
Fondaparinux sodium—Pain—Prednisolone—ankylosing spondylitis	0.00156	0.00156	CcSEcCtD
Fondaparinux sodium—Haemorrhage—Methotrexate—ankylosing spondylitis	0.00156	0.00156	CcSEcCtD
Fondaparinux sodium—Vision blurred—Prednisone—ankylosing spondylitis	0.00153	0.00153	CcSEcCtD
Fondaparinux sodium—Oedema—Dexamethasone—ankylosing spondylitis	0.00153	0.00153	CcSEcCtD
Fondaparinux sodium—Oedema—Betamethasone—ankylosing spondylitis	0.00153	0.00153	CcSEcCtD
Fondaparinux sodium—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.00153	0.00153	CcSEcCtD
Fondaparinux sodium—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.00153	0.00153	CcSEcCtD
Fondaparinux sodium—Insomnia—Triamcinolone—ankylosing spondylitis	0.00152	0.00152	CcSEcCtD
Fondaparinux sodium—Insomnia—Methylprednisolone—ankylosing spondylitis	0.00152	0.00152	CcSEcCtD
Fondaparinux sodium—Infection—Betamethasone—ankylosing spondylitis	0.00152	0.00152	CcSEcCtD
Fondaparinux sodium—Infection—Dexamethasone—ankylosing spondylitis	0.00152	0.00152	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.00151	0.00151	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.00151	0.00151	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.00151	0.00151	CcSEcCtD
Fondaparinux sodium—Anaemia—Prednisone—ankylosing spondylitis	0.00151	0.00151	CcSEcCtD
Fondaparinux sodium—Shock—Dexamethasone—ankylosing spondylitis	0.0015	0.0015	CcSEcCtD
Fondaparinux sodium—Shock—Betamethasone—ankylosing spondylitis	0.0015	0.0015	CcSEcCtD
Fondaparinux sodium—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.0015	0.0015	CcSEcCtD
Fondaparinux sodium—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.0015	0.0015	CcSEcCtD
Fondaparinux sodium—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.0015	0.0015	CcSEcCtD
Fondaparinux sodium—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.00149	0.00149	CcSEcCtD
Fondaparinux sodium—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.00149	0.00149	CcSEcCtD
Fondaparinux sodium—Tachycardia—Dexamethasone—ankylosing spondylitis	0.00149	0.00149	CcSEcCtD
Fondaparinux sodium—Tachycardia—Betamethasone—ankylosing spondylitis	0.00149	0.00149	CcSEcCtD
Fondaparinux sodium—Angioedema—Prednisone—ankylosing spondylitis	0.00149	0.00149	CcSEcCtD
Fondaparinux sodium—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.00148	0.00148	CcSEcCtD
Fondaparinux sodium—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.00148	0.00148	CcSEcCtD
Fondaparinux sodium—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.00148	0.00148	CcSEcCtD
Fondaparinux sodium—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.00148	0.00148	CcSEcCtD
Fondaparinux sodium—Vertigo—Prednisone—ankylosing spondylitis	0.00146	0.00146	CcSEcCtD
Fondaparinux sodium—Syncope—Prednisone—ankylosing spondylitis	0.00146	0.00146	CcSEcCtD
Fondaparinux sodium—Anorexia—Betamethasone—ankylosing spondylitis	0.00145	0.00145	CcSEcCtD
Fondaparinux sodium—Anorexia—Dexamethasone—ankylosing spondylitis	0.00145	0.00145	CcSEcCtD
Fondaparinux sodium—Urticaria—Prednisolone—ankylosing spondylitis	0.00145	0.00145	CcSEcCtD
Fondaparinux sodium—Fatigue—Triamcinolone—ankylosing spondylitis	0.00145	0.00145	CcSEcCtD
Fondaparinux sodium—Fatigue—Methylprednisolone—ankylosing spondylitis	0.00145	0.00145	CcSEcCtD
Fondaparinux sodium—Pain—Triamcinolone—ankylosing spondylitis	0.00144	0.00144	CcSEcCtD
Fondaparinux sodium—Loss of consciousness—Prednisone—ankylosing spondylitis	0.00143	0.00143	CcSEcCtD
Fondaparinux sodium—Hypotension—Dexamethasone—ankylosing spondylitis	0.00143	0.00143	CcSEcCtD
Fondaparinux sodium—Hypotension—Betamethasone—ankylosing spondylitis	0.00143	0.00143	CcSEcCtD
Fondaparinux sodium—Angiopathy—Methotrexate—ankylosing spondylitis	0.00142	0.00142	CcSEcCtD
Fondaparinux sodium—Immune system disorder—Methotrexate—ankylosing spondylitis	0.00141	0.00141	CcSEcCtD
Fondaparinux sodium—Convulsion—Prednisone—ankylosing spondylitis	0.00141	0.00141	CcSEcCtD
Fondaparinux sodium—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.00141	0.00141	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.00139	0.00139	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.00138	0.00138	CcSEcCtD
Fondaparinux sodium—Anxiety—Prednisone—ankylosing spondylitis	0.00138	0.00138	CcSEcCtD
Fondaparinux sodium—Insomnia—Betamethasone—ankylosing spondylitis	0.00138	0.00138	CcSEcCtD
Fondaparinux sodium—Insomnia—Dexamethasone—ankylosing spondylitis	0.00138	0.00138	CcSEcCtD
Fondaparinux sodium—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.00138	0.00138	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.00137	0.00137	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Betamethasone—ankylosing spondylitis	0.00137	0.00137	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.00137	0.00137	CcSEcCtD
Fondaparinux sodium—Malnutrition—Methotrexate—ankylosing spondylitis	0.00136	0.00136	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.00135	0.00135	CcSEcCtD
Fondaparinux sodium—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.00134	0.00134	CcSEcCtD
Fondaparinux sodium—Dyspepsia—Betamethasone—ankylosing spondylitis	0.00134	0.00134	CcSEcCtD
Fondaparinux sodium—Urticaria—Triamcinolone—ankylosing spondylitis	0.00134	0.00134	CcSEcCtD
Fondaparinux sodium—Urticaria—Methylprednisolone—ankylosing spondylitis	0.00133	0.00133	CcSEcCtD
Fondaparinux sodium—Dysgeusia—Methotrexate—ankylosing spondylitis	0.00133	0.00133	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.00133	0.00133	CcSEcCtD
Fondaparinux sodium—Oedema—Prednisone—ankylosing spondylitis	0.00133	0.00133	CcSEcCtD
Fondaparinux sodium—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.00133	0.00133	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.00133	0.00133	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.00133	0.00133	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Betamethasone—ankylosing spondylitis	0.00133	0.00133	CcSEcCtD
Fondaparinux sodium—Infection—Prednisone—ankylosing spondylitis	0.00132	0.00132	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.00132	0.00132	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.00132	0.00132	CcSEcCtD
Fondaparinux sodium—Back pain—Methotrexate—ankylosing spondylitis	0.00132	0.00132	CcSEcCtD
Fondaparinux sodium—Fatigue—Dexamethasone—ankylosing spondylitis	0.00132	0.00132	CcSEcCtD
Fondaparinux sodium—Fatigue—Betamethasone—ankylosing spondylitis	0.00132	0.00132	CcSEcCtD
Fondaparinux sodium—Shock—Prednisone—ankylosing spondylitis	0.00131	0.00131	CcSEcCtD
Fondaparinux sodium—Pain—Betamethasone—ankylosing spondylitis	0.00131	0.00131	CcSEcCtD
Fondaparinux sodium—Pain—Dexamethasone—ankylosing spondylitis	0.00131	0.00131	CcSEcCtD
Fondaparinux sodium—Nervous system disorder—Prednisone—ankylosing spondylitis	0.0013	0.0013	CcSEcCtD
Fondaparinux sodium—Tachycardia—Prednisone—ankylosing spondylitis	0.0013	0.0013	CcSEcCtD
Fondaparinux sodium—Skin disorder—Prednisone—ankylosing spondylitis	0.00129	0.00129	CcSEcCtD
Fondaparinux sodium—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.00128	0.00128	CcSEcCtD
Fondaparinux sodium—Vision blurred—Methotrexate—ankylosing spondylitis	0.00128	0.00128	CcSEcCtD
Fondaparinux sodium—Anorexia—Prednisone—ankylosing spondylitis	0.00127	0.00127	CcSEcCtD
Fondaparinux sodium—Anaemia—Methotrexate—ankylosing spondylitis	0.00126	0.00126	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.00126	0.00126	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.00126	0.00126	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.00125	0.00125	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.00125	0.00125	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.00124	0.00124	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.00124	0.00124	CcSEcCtD
Fondaparinux sodium—Vertigo—Methotrexate—ankylosing spondylitis	0.00122	0.00122	CcSEcCtD
Fondaparinux sodium—Urticaria—Betamethasone—ankylosing spondylitis	0.00121	0.00121	CcSEcCtD
Fondaparinux sodium—Urticaria—Dexamethasone—ankylosing spondylitis	0.00121	0.00121	CcSEcCtD
Fondaparinux sodium—Dizziness—Prednisolone—ankylosing spondylitis	0.00121	0.00121	CcSEcCtD
Fondaparinux sodium—Asthenia—Triamcinolone—ankylosing spondylitis	0.00121	0.00121	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.00121	0.00121	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.00121	0.00121	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Betamethasone—ankylosing spondylitis	0.00121	0.00121	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Betamethasone—ankylosing spondylitis	0.00121	0.00121	CcSEcCtD
Fondaparinux sodium—Asthenia—Methylprednisolone—ankylosing spondylitis	0.0012	0.0012	CcSEcCtD
Fondaparinux sodium—Insomnia—Prednisone—ankylosing spondylitis	0.0012	0.0012	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Prednisone—ankylosing spondylitis	0.00119	0.00119	CcSEcCtD
Fondaparinux sodium—Pruritus—Triamcinolone—ankylosing spondylitis	0.00119	0.00119	CcSEcCtD
Fondaparinux sodium—Cough—Methotrexate—ankylosing spondylitis	0.00119	0.00119	CcSEcCtD
Fondaparinux sodium—Pruritus—Methylprednisolone—ankylosing spondylitis	0.00119	0.00119	CcSEcCtD
Fondaparinux sodium—Convulsion—Methotrexate—ankylosing spondylitis	0.00118	0.00118	CcSEcCtD
Fondaparinux sodium—Dyspepsia—Prednisone—ankylosing spondylitis	0.00117	0.00117	CcSEcCtD
Fondaparinux sodium—Chest pain—Methotrexate—ankylosing spondylitis	0.00116	0.00116	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Prednisone—ankylosing spondylitis	0.00116	0.00116	CcSEcCtD
Fondaparinux sodium—Rash—Prednisolone—ankylosing spondylitis	0.00115	0.00115	CcSEcCtD
Fondaparinux sodium—Dermatitis—Prednisolone—ankylosing spondylitis	0.00115	0.00115	CcSEcCtD
Fondaparinux sodium—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.00115	0.00115	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00115	0.00115	CcSEcCtD
Fondaparinux sodium—Fatigue—Prednisone—ankylosing spondylitis	0.00115	0.00115	CcSEcCtD
Fondaparinux sodium—Headache—Prednisolone—ankylosing spondylitis	0.00115	0.00115	CcSEcCtD
Fondaparinux sodium—Constipation—Prednisone—ankylosing spondylitis	0.00114	0.00114	CcSEcCtD
Fondaparinux sodium—Confusional state—Methotrexate—ankylosing spondylitis	0.00112	0.00112	CcSEcCtD
Fondaparinux sodium—Dizziness—Triamcinolone—ankylosing spondylitis	0.00111	0.00111	CcSEcCtD
Fondaparinux sodium—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.00111	0.00111	CcSEcCtD
Fondaparinux sodium—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00111	0.00111	CcSEcCtD
Fondaparinux sodium—Infection—Methotrexate—ankylosing spondylitis	0.0011	0.0011	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Prednisone—ankylosing spondylitis	0.0011	0.0011	CcSEcCtD
Fondaparinux sodium—Asthenia—Betamethasone—ankylosing spondylitis	0.00109	0.00109	CcSEcCtD
Fondaparinux sodium—Asthenia—Dexamethasone—ankylosing spondylitis	0.00109	0.00109	CcSEcCtD
Fondaparinux sodium—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.00109	0.00109	CcSEcCtD
Fondaparinux sodium—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.00109	0.00109	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.00109	0.00109	CcSEcCtD
Fondaparinux sodium—Nausea—Prednisolone—ankylosing spondylitis	0.00109	0.00109	CcSEcCtD
Fondaparinux sodium—Pruritus—Dexamethasone—ankylosing spondylitis	0.00108	0.00108	CcSEcCtD
Fondaparinux sodium—Pruritus—Betamethasone—ankylosing spondylitis	0.00108	0.00108	CcSEcCtD
Fondaparinux sodium—Skin disorder—Methotrexate—ankylosing spondylitis	0.00108	0.00108	CcSEcCtD
Fondaparinux sodium—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.00107	0.00107	CcSEcCtD
Fondaparinux sodium—Vomiting—Triamcinolone—ankylosing spondylitis	0.00107	0.00107	CcSEcCtD
Fondaparinux sodium—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00107	0.00107	CcSEcCtD
Fondaparinux sodium—Rash—Triamcinolone—ankylosing spondylitis	0.00106	0.00106	CcSEcCtD
Fondaparinux sodium—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00106	0.00106	CcSEcCtD
Fondaparinux sodium—Anorexia—Methotrexate—ankylosing spondylitis	0.00106	0.00106	CcSEcCtD
Fondaparinux sodium—Rash—Methylprednisolone—ankylosing spondylitis	0.00106	0.00106	CcSEcCtD
Fondaparinux sodium—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00106	0.00106	CcSEcCtD
Fondaparinux sodium—Urticaria—Prednisone—ankylosing spondylitis	0.00106	0.00106	CcSEcCtD
Fondaparinux sodium—Headache—Triamcinolone—ankylosing spondylitis	0.00105	0.00105	CcSEcCtD
Fondaparinux sodium—Headache—Methylprednisolone—ankylosing spondylitis	0.00105	0.00105	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Prednisone—ankylosing spondylitis	0.00105	0.00105	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Prednisone—ankylosing spondylitis	0.00105	0.00105	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.00104	0.00104	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Betamethasone—ankylosing spondylitis	0.00104	0.00104	CcSEcCtD
Fondaparinux sodium—Hypotension—Methotrexate—ankylosing spondylitis	0.00104	0.00104	CcSEcCtD
Fondaparinux sodium—Dizziness—Dexamethasone—ankylosing spondylitis	0.00101	0.00101	CcSEcCtD
Fondaparinux sodium—Dizziness—Betamethasone—ankylosing spondylitis	0.00101	0.00101	CcSEcCtD
Fondaparinux sodium—Insomnia—Methotrexate—ankylosing spondylitis	0.001	0.001	CcSEcCtD
Fondaparinux sodium—Nausea—Triamcinolone—ankylosing spondylitis	0.000999	0.000999	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000997	0.000997	CcSEcCtD
Fondaparinux sodium—Nausea—Methylprednisolone—ankylosing spondylitis	0.000997	0.000997	CcSEcCtD
Fondaparinux sodium—Dyspnoea—Methotrexate—ankylosing spondylitis	0.00099	0.00099	CcSEcCtD
Fondaparinux sodium—Somnolence—Methotrexate—ankylosing spondylitis	0.000987	0.000987	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000979	0.000979	CcSEcCtD
Fondaparinux sodium—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000978	0.000978	CcSEcCtD
Fondaparinux sodium—Vomiting—Betamethasone—ankylosing spondylitis	0.00097	0.00097	CcSEcCtD
Fondaparinux sodium—Vomiting—Dexamethasone—ankylosing spondylitis	0.00097	0.00097	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000966	0.000966	CcSEcCtD
Fondaparinux sodium—Rash—Dexamethasone—ankylosing spondylitis	0.000962	0.000962	CcSEcCtD
Fondaparinux sodium—Rash—Betamethasone—ankylosing spondylitis	0.000962	0.000962	CcSEcCtD
Fondaparinux sodium—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000961	0.000961	CcSEcCtD
Fondaparinux sodium—Dermatitis—Betamethasone—ankylosing spondylitis	0.000961	0.000961	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000959	0.000959	CcSEcCtD
Fondaparinux sodium—Fatigue—Methotrexate—ankylosing spondylitis	0.000958	0.000958	CcSEcCtD
Fondaparinux sodium—Headache—Betamethasone—ankylosing spondylitis	0.000956	0.000956	CcSEcCtD
Fondaparinux sodium—Headache—Dexamethasone—ankylosing spondylitis	0.000956	0.000956	CcSEcCtD
Fondaparinux sodium—Asthenia—Prednisone—ankylosing spondylitis	0.000954	0.000954	CcSEcCtD
Fondaparinux sodium—Pain—Methotrexate—ankylosing spondylitis	0.00095	0.00095	CcSEcCtD
Fondaparinux sodium—Pruritus—Prednisone—ankylosing spondylitis	0.00094	0.00094	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000915	0.000915	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Prednisone—ankylosing spondylitis	0.000909	0.000909	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000908	0.000908	CcSEcCtD
Fondaparinux sodium—Nausea—Betamethasone—ankylosing spondylitis	0.000906	0.000906	CcSEcCtD
Fondaparinux sodium—Nausea—Dexamethasone—ankylosing spondylitis	0.000906	0.000906	CcSEcCtD
Fondaparinux sodium—Urticaria—Methotrexate—ankylosing spondylitis	0.000882	0.000882	CcSEcCtD
Fondaparinux sodium—Dizziness—Prednisone—ankylosing spondylitis	0.000879	0.000879	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000878	0.000878	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000878	0.000878	CcSEcCtD
Fondaparinux sodium—Vomiting—Prednisone—ankylosing spondylitis	0.000845	0.000845	CcSEcCtD
Fondaparinux sodium—Rash—Prednisone—ankylosing spondylitis	0.000838	0.000838	CcSEcCtD
Fondaparinux sodium—Dermatitis—Prednisone—ankylosing spondylitis	0.000837	0.000837	CcSEcCtD
Fondaparinux sodium—Headache—Prednisone—ankylosing spondylitis	0.000833	0.000833	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000818	0.000818	CcSEcCtD
Fondaparinux sodium—Asthenia—Methotrexate—ankylosing spondylitis	0.000797	0.000797	CcSEcCtD
Fondaparinux sodium—Nausea—Prednisone—ankylosing spondylitis	0.000789	0.000789	CcSEcCtD
Fondaparinux sodium—Pruritus—Methotrexate—ankylosing spondylitis	0.000786	0.000786	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Methotrexate—ankylosing spondylitis	0.00076	0.00076	CcSEcCtD
Fondaparinux sodium—Dizziness—Methotrexate—ankylosing spondylitis	0.000734	0.000734	CcSEcCtD
Fondaparinux sodium—Vomiting—Methotrexate—ankylosing spondylitis	0.000706	0.000706	CcSEcCtD
Fondaparinux sodium—Rash—Methotrexate—ankylosing spondylitis	0.0007	0.0007	CcSEcCtD
Fondaparinux sodium—Dermatitis—Methotrexate—ankylosing spondylitis	0.0007	0.0007	CcSEcCtD
Fondaparinux sodium—Headache—Methotrexate—ankylosing spondylitis	0.000696	0.000696	CcSEcCtD
Fondaparinux sodium—Nausea—Methotrexate—ankylosing spondylitis	0.00066	0.00066	CcSEcCtD
